author-photo

Mariele Goebeler

University of Würzburg

31

Papers

2420

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

Cutaneous epithelioid hemangiomas show somatic mutations in the MAPK pathway.

2021 British Journal of Dermatology
Show All
- Source
- Cite
- Save
Citations (0)
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group.

2017 Leukemia
Show All
- Source
- Cite
- Save
Citations (23)
Pathogenesis-Based Development of Potential Mitigation Strategies for Blinatumomab-Associated Neurologic Events (NEs)

2016 Blood
Show All
- Source
- Cite
- Save
Citations (6)
Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma with the Bispecific T-Cell Engager (BiTE®) Antibody Construct Blinatumomab: Primary Analysis Results from an Open-Label, Phase 2 Study

2014 Blood
Show All
- Source
- Cite
- Save
Citations (22)
myeloid leukemia Drug treatment is superior to allografting as first-line therapy in chronic

2013
Show All
- Source
- Cite
- Save
Citations (0)
Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange.

2012 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (37)
Blinatumomab Monotherapy Shows Efficacy in Patients with Relapsed Diffuse Large B Cell Lymphoma

2011 Blood
Show All
- Source
- Cite
- Save
Citations (25)
Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer

2011 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (36)
CD19/CD3 Bispecific Antibody Blinatumomab (MT-103) Is Highly Effective In Treatment of Patients with Minimal Residual Disease From Chemotherapy-Resistant B-Precursor Acute Lymphoblastic Leukemia

2010 Blood
Show All
- Source
- Cite
- Save
Citations (7)
Deferasirox (Exjade®) Treatment of Chelation-Naive and Pre-Chelated MDS Patients with Transfusional Iron-Overload in the Medical Practice:Results From the Observational Studies Extend and Exjange.

2009 Blood
Show All
- Source
- Cite
- Save
Citations (2)